Health Populi
AUGUST 3, 2018
voters, across the three-party landscape, agree on two healthcare issues this year: coverage of pre-existing conditions, and lowering the consumer-facing costs of prescription drugs. This is the tactic that most Americans say could lower prescription drug prices. There’s growing evidence that a majority of U.S.
Health Populi
JANUARY 29, 2019
The growing adoption of artificial intelligence and machine learning by pharma companies to drive more efficient drug discovery. More philanthropic organizations targeting neglected tropical and public health diseases. The increased use of real-world evidence (RWE) and patient involvement in clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Jane Sarashon
FEBRUARY 27, 2024
In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescription drugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.
Health Populi
APRIL 25, 2023
middle-class households finding that health care has returned to the #1 household fiscal concern ahead of inflation in 2023. That’s represented by the lighter blue line in the first chart.
Health Populi
JANUARY 18, 2019
Chan School of Public Health with POLITICO looked into Americans’ Health and Education Priorities for the New Congress in 2019.
Health Populi
OCTOBER 24, 2022
These are shown in the first diagram from the report, breaking out factors that have exacerbated challenges on both the demand and supply side of the American health economy. Many of these were already in motion before the COVID-19 pandemic emerged; the public health crisis exacerbated several of them. In the U.S.,
Healthcare Law Blog
FEBRUARY 22, 2023
All rebate payments will be deposited into the Medicare Prescription Drug Account in the Federal Supplementary Medical Insurance Trust Fund. FOOTNOTES [1] See Press Release – HHS Releases Initial Guidance for Medicare Prescription Drug Inflation Rebate Program, CMS (Feb. 9, 2023). [2]
Expert insights. Personalized for you.
67 
Let's personalize your content